Aortobifemoral graft infection with Mycobacterium tuberculosis: treatment with abscess drainage, debridement, and long-term administration of antibiotic agents.
Aortic graft infection with Mycobacterium tuberculosis is rare. We report a patient with a Dacron aortobifemoral prosthetic graft infection secondary to tuberculosis. The infection was successfully treated with surgical drainage without removal of the graft, and long-term antimycobacterial medications. A review of the literature contains only 1 other report of tuberculosis graft infection and treatment. We discuss a rare form of aortic graft infection from M tuberculosis and its treatment.
Raffetto
Joseph D
JD
Department of Surgery, Boston Univerity Medical Center, MA, USA. joseph.raffetto@med.va.gov
Bernardo
John
J
Menzoían
James O
JO
D018784:Abdominal Abscess / Q000382:microbiology / Q000628:therapy*; D000995:Antitubercular Agents / Q000627:therapeutic use; D001012:Aorta, Abdominal; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects*; D003646:Debridement / Q000379:methods; D004322:Drainage / Q000379:methods; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007538:Isoniazid / Q000627:therapeutic use; D008875:Middle Aged; D009169:Mycobacterium tuberculosis; D016459:Prosthesis-Related Infections / Q000382:microbiology / Q000628:therapy*; D017828:Rifabutin / Q000627:therapeutic use; D013625:Takayasu Arteritis / Q000628:therapy; D013997:Time Factors; D016896:Treatment Outcome; D014376:Tuberculosis / Q000628:therapy*; D014381:Tuberculosis, Cardiovascular / Q000628:therapy
D000995:Antitubercular Agents; D007166:Immunosuppressive Agents; D017828:Rifabutin; D007538:Isoniazid